An update on kinase inhibitors from EHA 2017
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
Side-effect of idelalisib and its use in chronic lymphocytic leukemia
Prognostic markers for CLL - how do they help determine who gets which treatment?
Identifying predictive markers for CLL